The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
- Resource Type
- article
- Source
- Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
- Subject
Science - Language
- English
- ISSN
- 2041-1723